Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
08/08/202210:42AMBusiness WireGSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwideNYSE:GSKGSK plc
07/27/20222:26PMDow Jones NewsGSK Lupus Treatment Approved for Pediatric Patients by U.S. FDANYSE:GSKGSK plc
07/27/20221:20PMBusiness WireGSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus NephritisNYSE:GSKGSK plc
07/27/20224:09AMDow Jones NewsGSK 2Q Adjusted Operating Profit, Sales Rose; Raises 2022 Outlook -- 2nd UpdateNYSE:GSKGSK plc
07/27/20223:26AMDow Jones NewsGSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 Outlook -- UpdateNYSE:GSKGSK plc
07/27/20222:53AMDow Jones NewsGSK 2Q Operating Profit Slipped Despite Higher Sales; Raises 2022 OutlookNYSE:GSKGSK plc
07/19/20225:02AMTipRanksWhat Does the Haleon Spinoff Mean for GSK Shareholders?NYSE:GSKGSK plc
07/11/20224:12PMDow Jones NewsGSK Expects to Distribute Over 50 Million Influenza Vaccine Doses for 2022-23 U.S. Flu SeasonNYSE:GSKGSK plc
07/11/20223:21PMBusiness WireGSK prepares US for 2022-23 flu season with over 50 million influenza vaccine dosesNYSE:GSKGSK plc
07/06/202212:07PMDow Jones NewsGSK Shareholders Approve Consumer Healthcare Business SpinoffNYSE:GSKGSK plc
07/04/20222:54AMDow Jones NewsSareum Holdings Says GSK Completes Acquisition of Sierra OncologyNYSE:GSKGSK plc
06/29/20228:00AMBusiness WireGSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma CommunityNYSE:GSKGSK plc
06/28/20222:49AMDow Jones NewsGSK Submits Shingrix Regulatory Application in Japan for Adults 18 and OlderNYSE:GSKGSK plc
06/24/20222:21AMDow Jones NewsSanofi, GSK Report Successful Vaccine Study Against OmicronNYSE:GSKGSK plc
06/23/20227:43AMDow Jones NewsGSK to Invest GBP1 Billion Tackling Infectious Diseases in Low-Income CountriesNYSE:GSKGSK plc
06/23/20227:00AMGlobeNewswire Inc.Viridian Therapeutics Appoints Carrie Melvin as Chief Operating OfficerNYSE:GSKGSK plc
06/13/20222:43AMDow Jones NewsSanofi-GSK Covid-19 Booster Showing Strong Immune Response, Sanofi SaysNYSE:GSKGSK plc
06/10/20222:44AMDow Jones NewsGSK Says RSV Vaccine Candidate Showed Significant Efficacy in Phase 3 TrialNYSE:GSKGSK plc
06/09/202212:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/06/202210:00AMBusiness WireGSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and olderNYSE:GSKGSK plc
06/06/20226:51AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
06/06/20222:47AMDow Jones NewsU.S. FDA Approves GSK's Priorix VaccineNYSE:GSKGSK plc
06/02/20223:16PMPR Newswire (US)/C O R R E C T I O N -- GSK Consumer Healthcare/NYSE:GSKGSK plc
06/02/202212:37PMPR Newswire (US)The Food Fight is Over: TUMS® Declares It is Time to Love Food BackNYSE:GSKGSK plc
06/01/202212:37PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/31/20227:32AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/31/20227:30AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
05/31/20222:43AMDow Jones NewsGSK to Buy Affinivax for Up to $3.3 BillionNYSE:GSKGSK plc
05/27/20224:13PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:GSKGSK plc
05/27/20222:40AMDow Jones NewsGSK's Cervarix Two-Dose Vaccine Schedule Approved in ChinaNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK